Effect of Buflomedil Chlorhydrate on Local Oxygen Delivery in Peripheral Vascular Disease
- 1 June 1989
- journal article
- research article
- Published by SAGE Publications in Angiology
- Vol. 40 (6) , 559-562
- https://doi.org/10.1177/000331978904000607
Abstract
Modifications in transcutaneous oxygen pressure (TcPO2), induced by the administration of 3 mg/kg/day buflomedil chlorhydrate for seven days were evaluated in 12 subjects suffering from peripheral vascular disease (PVD). After the treatment a significant increase in TcPO 2 basal values was observed in Stage III and Stage IV PVD patients (+32.2%) while a significant reduction of 12 % in the half-recovery time to basal val ues after an induced ischemia was re corded in Stage II PVD patients by the seventh day. Buflomedil did not, however, cause any significant varia tions in the ankle/arm pressure ratio or in the plethysmographic peak flow.This publication has 8 references indexed in Scilit:
- Transcutaneous Oxygen Tension Behavior in the Different Stages of Peripheral Vascular Disease and Its Correlation With Ankle/Arm Pressure Ratio and Calf Blood FlowAngiology, 1987
- Transcutaneous oxygen recovery and toe pulse reappearance time in the assessment of peripheral vascular disease.Circulation, 1985
- Pedal blood flow and transcutaneous PO2 in normal subjects and in patients suffering from severe arterial occlusive diseaseClinical Physiology and Functional Imaging, 1984
- The Use of Transcutaneous Oxygen Tension Measurements in the Diagnosis of Peripherial Vascular InsufficiencyAnnals of Surgery, 1984
- Buflomedil in Arterial Occlusive Disease: Results of a Controlled Multicenter StudyAngiology, 1984
- Effects of Buflomedil on Erythrocyte DeformabilityAngiology, 1981
- Comparison of Safety and Efficacy of Buflomedil and Naftidrofuryl in the Treatment of Intermittent ClaudicationAngiology, 1981